Scientific Poster Guidelines



Posters display your work in a concise form, enabling conference attendees to grasp the essentials of the subject in a reasonable time frame.

Submission deadline for scientific posters is 5pm AEST 29 July 2019


Posters are prepared in English and are displayed in poster form on display boards during the conference.

In addition, the delegates receive a link to an electronic copy of your poster on a website so they can read it during and after the conference and make further contact with you as the author.

Preparing an electronic poster is a little different from conventional posters. You need to submit your electronic poster in ONE PowerPoint slide, saved as a PDF, exactly the same way you submit it to a printer. This ONE slide will contain the same content that you display on the printed poster board display.

Only online abstracts will be accepted. Please submit your abstract according to the format described above.

Download the Poster Presentation Submission Template.

Title and Author – To be typed directly into the online submissions form.
Do not include in your abstract submissions document.

You will be asked to provide the following details:

Title: Use a maximum of 20 words

Authors: List a maximum of eight names

Institution: One primary affiliation should be listed for each author

Please note that the first author will be considered the recipient of any conference prizes awarded.

Abstract Format 
Using the following structured abstract format, with no more than 400 words you must submit your abstracts in a separate word file using the template provided. Abstracts that do not comply with the submission guidelines (e.g. incorrect font, incorrect formatting, more than 400 words) unfortunately cannot be accepted.

You must use 12 point, sentence case, Times New Roman

Objective: State the main study questions and identify any hypotheses being tested.

Design: State the study type, e.g. Randomised controlled trial, Systematic review, Cost-benefit analysis, or Retrospective cohort study.


Method: Describe the participants (report age as mean (SD) in years and months; sex as ‘n=’ (not %); relevant classification/s; recruitment method), instrumentation and measures (use SI units, except for blood pressure use mmHg, convert imperial units to metric), procedure and statistical analyses used.

Results: Identify the main study outcomes including results of any statistical tests (show standard deviations as (SD), not ±; do not use percentages for sample sizes below 50; abbreviate probability with a lower case italicized p). Please note that it is not sufficient just to state that ‘results will be presented’.

Conclusion: State conclusions as clinical implications and future research directions.

References: If necessary, a maximum of 3 references will be accepted, but will be included in your word count.

Figures and Tables: Are not permitted and will be removed.

Additional Information: Additional information such as acknowledgements, disclosures and funding sources are not required and will be removed.


Author Notification 

You will be notified of acceptance of your submission by 10 September 2019 giving adequate time for travel arrangements to be made. All presenters for paper, poster, workshops and breakfast sessions must pay for conference registration, co-ordinate their own accommodation and travel arrangements and where applicable organise their own travel visas. Upon receiving notification of acceptance, authors are required to notify the Conference Office of their intent to participate/present at the conference. Authors who fail to notify the Conference Office by 25 September 2019 may have their presentations withdrawn from the program at the discretion of the committee.


Terms and Conditions
By submitting an abstract you are agreeing to the following terms and conditions:

  • This abstract been NOT presented at a previous AusACPDM conference
  • This abstract NOT been printed in a previous journal supplement for a conference
  • The research has NOT been published in a journal at the time of abstract submission
  • This abstract has been proofed by the lead author and research team
  • The research team agrees to the abstract being printed in the DMCN conference supplement
  • The research team agree to the abstract being viewable via the AusACPDM website
  • The patients in any photographs have given permission for their photograph to be used for this purpose